INHIBIKASE THERAPEUTICS INC
IKT·45719W106·UQ·Common Stock·Healthcare - Biotechnology
IKT (INHIBIKASE THERAPEUTICS INC) is held by 67 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($15.8M), Blackstone Inc. ($12.1M), VANGUARD CAPITAL MANAGEMENT LLC ($10M). Net institutional sentiment: Mixed.
67
Holders
(4 Elite)
$71.3M
Total Value
66% (68)
Consensus
45 buying - 23 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Jul 31, 2026 · Activists none · Congress none
InsiderBNBERMAN DENNIS NExercise 22K shJul 30, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Other 18.0M shJul 29, 2026
InsiderAVAurentz VincentDispFeb 21, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 73
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer